Latest Market Reaction News

Ridley Corporation has successfully closed its retail entitlement offer, raising $26 million as part of a $125 million capital raise to fund its $300 million acquisition of Incitec Pivot’s fertiliser distribution business.

OFX Group Limited has responded to ASX concerns over its FY25 earnings disclosure, confirming earnings below consensus but no breach of continuous disclosure rules.

Streamplay Studio Limited has had its ASX trading suspension lifted following a significant announcement about a new agreement with a gaming platform, signaling renewed investor interest.

Talius Group Limited has secured shareholder approval to consolidate its shares on a 10-for-1 basis, aiming to better align its capital structure with industry peers. The move affects all ordinary shares and performance rights, effective June 4, 2025.

CAQ Holdings Limited has resumed trading on the ASX following the release of its annual report and an update on a new debt facility and company restructure.

Fisher & Paykel Healthcare has announced an ordinary dividend of NZD 0.28235294 per share for the six months ending March 31, 2025, payable on July 4. The dividend is unfranked and includes a supplementary component, with a 15% withholding tax applied.

Aspen Group has launched a $4 million Security Purchase Plan (SPP) at $2.90 per security, offering eligible investors a chance to buy new stapled securities without brokerage fees. This move follows a recent $70 million institutional placement aimed at strengthening the balance sheet for future acquisitions.

Nufarm Limited confirms its half-year earnings align closely with analyst expectations despite a late-stage $16 million inventory valuation adjustment. The company maintains compliance with ASX disclosure rules amid market scrutiny.

Cash Converters has announced its exit from the Small Amount Credit Contract payday lending sector, signaling a strategic shift away from this controversial market segment.

betr Entertainment has successfully closed the retail portion of its $130 million equity raise, securing funds to advance its strategic acquisition of PointsBet Holdings.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Bryah Resources has requested an immediate suspension of its shares on the ASX as it prepares to announce a significant acquisition. The suspension follows a recent trading halt and is expected to last until the announcement or the resumption of trading on May 21.